Docampo-SimònA, Sánchez-PujolMJ, Pastor-NietoMA, et al.Patch testing in patients with severe atopic Dermatitis treated with dupilumab: a multicentric approach in Spain. Dermatitis, 2023; 34(4):315–322.
2.
RussoF, RizzoA, SantiF, et al.A paradoxical head and neck erythema: an adverse event due to dupilumab in adult patients with atopic Dermatitis. Int J Dermatol, 2022; 61(6):e204–e206.
3.
VittrupI, KroghNS, LarsenHHP, et al.A nationwide 104 weeks real-world study of dupilumab in adults with atopic Dermatitis: Ineffectiveness in head-and-neck Dermatitis. J Eur Acad Dermatol Venereol, 2023; 37(5):1046–1055.
4.
Ruge IF et al. Dupilumab treatment in two patients with severe allergic contact Dermatitis caused by sesquiterpene lactones. Contact Dermatitis, 2020; 83(2)137–139.
5.
GalloR, OddeninoG, TraveI, et al.Contact sensitivity to sesquiterpene lactone mix and artichoke in a patient with severe recurrent Dermatitis: a puzzling case. Contact Dermatitis, 2023; 88(2):156–158.
